March 17, 2026 – Roche introduced an enlargement of its international AI infrastructure, deploying a large-scale AI manufacturing unit powered by a full stack of next-generation NVIDIA accelerated computing and AI. With 2,176 high-performance GPUs in areas throughout america and Europe and embedded all through the worth chain, this infrastructure is designed to speed up the event of diagnostic options and therapies. With this newest funding, Roche’s mixed on-premises and cloud GPU infrastructure now exceeds 3,500 Blackwell GPUs, which is the biggest introduced GPU footprint out there to a pharmaceutical firm.

This computational enlargement marks the following section of a strategic NVIDIA collaboration that started in 2023. By leveraging the NVIDIA AI infrastructure, Roche accelerates drug improvement via high-quality information and breakthrough AI.

Proceed studying